Effects of Docosahexaenoic Acid on Chemokine Expression in Human Conjunctival Fibroblasts.

Chinnery Holly R., et al.
Current eye research, 2019

Abstract

Purpose

We assessed the production of chemokines by human conjunctival fibroblasts in response to inflammation and the effects of omega (ω)-3 fatty acids on chemokine expression.

Methods

Primary cultures of human conjunctival fibroblasts were incubated with interleukin-4 (IL-4) and tumor necrosis factor-alpha (TNF-α). The expression of eotaxin-1 and RANTES in response to pretreatment with docosahexaenoic acid (DHA) was investigated. Moreover, western blotting was used to evaluate the effects of DHA on the activation of nuclear factor (NF)-κB and signal transducer and activator of transcription 6 (STAT6).

Results

The expression of eotaxin-1 mRNA was significantly suppressed by pretreatment with DHA with IL-4 and TNF-α costimulation. RANTES expression was similarly suppressed, but the difference was not significant. The secretion of eotaxin-1 and RANTES was significantly lower in DHA-pretreated cells than in vehicle-treated cells. Western blotting for NF-κB and STAT6 showed that these proteins were downregulated in the DHA pretreatment group compared with those in the vehicle control group.

Conclusion

The results of this study suggested that DHA could have applications in the management of allergic inflammation.

Keywords

Human conjunctival fibroblast; NF-κB; RANTES; STAT6; docosahexaenoic acid; eotaxin-1

PMID:31364439
DOI:10.1080/02713683.2019.1648832
Category:Eye Health

Articles similar to "Effects of Docosahexaenoic Acid on Chemokine Expression in Human Conjunctival Fibroblasts."

  • The role of Docosahexaenoic Acid in Eye Health: Omega-3 supplementation is neuroprotective to corneal nerves in dry eye disease: a pilot study. (PURPOSE: To investigate whether oral, long-chain omega-3 (ω-3) essential fatty acid (EFA) supplementation, for 3 months, induces changes to the central corneal sub-basal nerve plexus in dry eye disease and whether nerve alterations correlate with clinical findings... These pilot study findings suggest that ω-3 EFA supplementation imparts neuroprotective effects in the corneal sub-basal plexus that correlate with the extent of tear osmolarity normalisation. )

Previous article

The antioxidants in the process of ocular pathology.

Next article

Omega-3 supplementation is neuroprotective to corneal nerves in dry eye disease: a pilot study.